EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?

Marina Canyelles iD, Carla Borràs, Noemí Rotllan iD, Mireia Tondo iD, Joan Carles Escolà-Gil iD, Francisco Blanco-Vaca iD

International Journal of Molecular Sciences · 18.01.2023 · 24 (3) · 1940

DOI: 10.3390/ijms24031940 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.01.2023. Verfasst von Marina Canyelles und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 208-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministry of Economy, Industry and Competitiveness, Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trimethylamine-N-oxide (TMAO) is the main diet-induced metabolite produced by the gut microbiota, and it is mainly eliminated through renal excretion. TMAO has been correlated with an increased risk of atherosclerotic cardiovascular disease (ASCVD) and related complications, such as cardiovascular mortality or major adverse cardiovascular events (MACE). Meta-analyses have postulated that high circulating TMAO levels are associated with an increased risk of cardiovascular events and all-cause mortality, but the link between TMAO and CVD remains not fully consistent. The results of prospective studies vary depending on the target population and the outcome studied, and the adjustment for renal function tends to decrease or reverse the significant association between TMAO and the outcome studied, strongly suggesting that the association is substantially mediated by renal function. Importantly, one Mendelian randomization study did not find a significant association between genetically predicted higher TMAO levels and cardiometabolic disease, but another found a positive causal relationship between TMAO levels and systolic blood pressure, which—at least in part—could explain the link with renal function. The mechanisms by which TMAO can increase this risk are not clearly elucidated, but current evidence indicates that TMAO induces cholesterol metabolism alterations, inflammation, endothelial dysfunction, and platelet activation. Overall, there is no fully conclusive evidence that TMAO is a causal factor of ASCVD, and, especially, whether TMAO induces or just is a marker of hypertension and renal dysfunction requires further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCardiovascular DiseasesAtherosclerosisHumansProspective StudiesMethylamines

Stichwörter der Autor:innen

CVDTMAOatherosclerosismortalityprospectiverenal function

Substanzen

trimethyloxamineMethylamines

Autor:innen und Institutionen

  • Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain.
  • CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
  • Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, 08041 Barcelona, Spain.
  • Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain.

ORCID-Profile: Marina Canyelles, Noemí Rotllan, Mireia Tondo, Joan Carles Escolà-Gil, Francisco Blanco-Vaca

Förderung

  • Instituto de Salud Carlos III
  • Ministry of Economy, Industry and Competitiveness
  • Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa”
  • Ministerio de Ciencia, Innovación y Universidades
  • Red de Investigación en “Enfermedades Metabólicas y Cáncer”
  • FPU (Formación de Profesorado Universitario)

Zitieren

APA

Canyelles, M., Borràs, C., Rotllan, N., Tondo, M., Escolà-Gil, J. C., & Blanco-Vaca, F. (2023). Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?. International Journal of Molecular Sciences, 24(3), 1940. https://doi.org/10.3390/ijms24031940

Vancouver

Canyelles M, Borràs C, Rotllan N, Tondo M, Escolà-Gil JC, Blanco-Vaca F. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?. International Journal of Molecular Sciences. 2023;24(3):1940. doi:10.3390/ijms24031940

BibTeX
@article{Canyelles2023,
  author = {Canyelles, Marina and Borràs, Carla and Rotllan, Noemí and Tondo, Mireia and Escolà-Gil, Joan Carles and Blanco-Vaca, Francisco},
  title = {Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {1940},
  doi = {10.3390/ijms24031940}
}
Kostenlos starten →